Chiropractors in Wilton, CT Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Dr. Stephen Matochik, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 7 Danbury Rd, Wilton, CT 06897 Phone: 203-762-3400 |
 Maryanne Smith Ducey, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 30 Fawn Ridge Ln, Wilton, CT 06897 Phone: 203-246-8003 |
 South Wilton Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 7 Danbury Road, Wilton, CT 06897 Phone: 203-762-3400 |
Chiropractic Health Center Of Wilton Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 126 Old Ridgefield Rd, Wilton, CT 06897 Phone: 203-834-1515 Fax: 203-762-7210 |
Dr. Mary A Winston, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 126 Old Ridgefield Rd, Wilton, CT 06897 Phone: 203-834-1515 Fax: 203-762-7210 |
Dr. Elihu L Rosen, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 465 Danbury Rd, #6, Wilton, CT 06897 Phone: 203-762-2244 Fax: 203-761-0622 |
News Archive
Acceleron commences ACE-536 phase 2 study in beta-thalassemia
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced the initiation of a phase 2 study of its novel, investigational protein therapeutic, ACE-536, to treat patients with beta-thalassemia, a genetic hematologic disorder causing chronic and life-threatening anemia and serious complications affecting the spleen, liver and heart.
Women who suffer early and severe trauma can improve psychological symptoms
A UCLA-led study of HIV-positive women who were sexually abused as children has found that the more severe their past trauma, the greater their improvement in an intervention program designed to ease their psychological suffering.
CDC releases new data showing the distribution of Zika transmitting mosquitoes in the US
The U.S. Centers for Disease Control and Prevention (CDC) asked local public healthcare professionals to gather information about the geographic distribution of these two mosquito species as a result of the growing apprehensions about Zika virus since 2015.
COTI's novel small molecule effective against pancreatic cancer in animal model
Critical Outcome Technologies Inc. announced more positive results today from animal experiments carried out at a prominent Canadian cancer research facility. This new series of experiments adds to the impressive data package for COTI-2, demonstrating efficacy both as a single agent and in combination with current first line therapies, as well as low toxicity in several different animal models of human cancers.
› Verified 2 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Chiropractors
Podiatrists